Cargando…

Chemotherapy of non-small cell lung cancer.

Detalles Bibliográficos
Autor principal:	Williams, C. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1989
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247340/ https://www.ncbi.nlm.nih.gov/pubmed/2553089

Ejemplares similares

Adjuvant chemotherapy of non-small-cell lung cancer
por: Douillard, J.Y.
Publicado: (2013)

Adjuvant Chemotherapy of Non-Small Cell Lung Cancer
por: Pirker, Robert
Publicado: (2012)

Chemotherapy in non-small cell lung cancer: opportunities for advancement
por: Akhtari, Mani, et al.
Publicado: (2016)

Polymerized human hemoglobin increases the effectiveness of cisplatin-based chemotherapy in non-small cell lung cancer
por: Lucas, Alfredo, et al.
Publicado: (2020)

Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study.
por: Millward, M. J., et al.
Publicado: (1993)

Adjuvant Chemotherapy for Early Stage Non-Small Cell Lung Cancer
por: Patel, Manali I., et al.
Publicado: (2011)

Chemotherapy: A partnership with immunotherapy in non‐small cell lung cancer
por: Mendes, Ana Sofia, et al.
Publicado: (2022)

The not so small role of adjuvant chemotherapy in resected non-small cell lung cancer
por: Almquist, Daniel R., et al.
Publicado: (2021)

Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer
por: Talebian Yazdi, Mehrdad, et al.
Publicado: (2016)

Neoadjuvant immunochemotherapy with pembrolizumab plus chemotherapy in resectable non-small cell lung cancer
por: Chen, Yulong, et al.
Publicado: (2023)

Lobe‐specific analysis of perioperative chemotherapy for non‐small cell lung cancer patients
por: Lei, Xi, et al.
Publicado: (2023)

Adjuvant chemotherapy in pathological node-negative non-small cell lung cancer
por: Cheng, Ya-Fu, et al.
Publicado: (2023)

Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials
por: Vardy, Janette, et al.
Publicado: (2009)

Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer
por: Harada, Guilherme, et al.
Publicado: (2021)

Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
por: Jiang, Wenxiao, et al.
Publicado: (2021)

The response of cerebral metastases in small cell lung cancer to systemic chemotherapy.
por: Twelves, C. J., et al.
Publicado: (1990)

Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
por: Fujimoto, Daichi, et al.
Publicado: (2023)

Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patients
por: Tang, Ning, et al.
Publicado: (2016)

Chemotherapy plus Erlotinib versus Chemotherapy Alone for Treating Advanced Non-Small Cell Lung Cancer: A Meta-Analysis
por: Xu, J. L., et al.
Publicado: (2015)

A Case of Residual Non-Small Cell Lung Cancer Cells Coexisting With Newly Developed Small Cell Lung Cancer Cells in Ascitic Fluid after Chemotherapy for Non-Small Cell Lung Cancer
por: Park, Sang Hyuk, et al.
Publicado: (2014)

Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer
por: Belbaraka, Rhizlane, et al.
Publicado: (2010)

Patients at risk of chemotherapy-associated toxicity in small cell lung cancer.
por: Morittu, L., et al.
Publicado: (1989)

Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
por: Ellis, P. A., et al.
Publicado: (1995)

Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients
por: Lim, Jeong Uk, et al.
Publicado: (2018)

Efficacy of Pemetrexed-based Chemotherapy in Comparison to Non-Pemetrexed-based Chemotherapy in Advanced, ALK+ Non-Small Cell Lung Cancer
por: Jo, Jaemin, et al.
Publicado: (2018)

Determinants of Myelosuppression in the Treatment of Non‐small Cell Lung Cancer with Cisplatin‐containing Chemotherapy
por: Matsui, Kaoru, et al.
Publicado: (1996)

Factors Associated with the Decision to Decline Chemotherapy in Metastatic Non-Small Cell Lung Cancer
por: Jabbal, Iktej Singh, et al.
Publicado: (2023)

Effect of prior antibiotic or chemotherapy treatment on immunotherapy response in non-small cell lung cancer
por: Nyein, Andrew F., et al.
Publicado: (2022)

Evaluation of reactive oxygen metabolites in patients with non-small cell lung cancer after chemotherapy
por: Wakabayashi, Toru, et al.
Publicado: (2014)

Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers
por: Marchal, Marine, et al.
Publicado: (2023)

Role of chemotherapy for survival in patients with second primary non‐small cell lung cancer
por: Wang, Zhile, et al.
Publicado: (2020)

Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer
por: Tu, Zegui, et al.
Publicado: (2021)

Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer
por: Chaudhary, Kunal R., et al.
Publicado: (2022)

Maintenance Chemotherapy Use for Advanced Non-Small Cell Lung Cancer in an Australian Cancer Centre
por: Wann, Alysson, et al.
Publicado: (2012)

Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer
por: Salaroglio, Iris C., et al.
Publicado: (2022)

Sex Differences and Adverse Effects between Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer
por: Tsiouda, Theodora, et al.
Publicado: (2020)

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)
por: Assi, Hazem I., et al.
Publicado: (2023)

Long term survival of small cell lung cancer patients after chemotherapy.
por: van der Gaast, A., et al.
Publicado: (1993)

Prognostic significance of circulating tumor cells in non-small cell lung cancer patients undergoing chemotherapy
por: Tong, Bing, et al.
Publicado: (2017)

Cost-effectiveness of cemiplimab plus chemotherapy versus chemotherapy for the treatment of advanced non-small cell lung cancer
por: Liang, Xueyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rrqmf64pevtsfph6r59ljgv39f